Femasys Inc (FEMY) Stock Price, Quote & News

Company Profile

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination solution; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; FemCath, a cornual balloon catheter for selective fallopian tube evaluation; and FemChec, a controlled contrast-genera...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 770 500 3910

Fax: 404 581 5903

Website: www.femasys.com

Address:

3950 Johns Creek Court, Suite 100, Suwanee, United States

JJBurch Aug. 20 at 4:05 AM

It appears to me that $PMCB is about to acquire BOTH $TNFA and $FEMY within the next few weeks.

0 · Reply

stoneblood Aug. 20 at 1:19 AM

$FEMY MM's flushing out the impatient before dropping the fembloc FDA approval news grabbed some 0.67s today yum

0 · Reply

Mirto Aug. 20 at 1:11 AM

$FEMY $9000 clearing Thursday. Buying more.

0 · Reply

ExcelsiorHub Aug. 19 at 9:56 PM

$FEMY Bought a small position in @.70 cents.

1 · Reply

NEWBIGTECH Aug. 19 at 9:39 PM

$FEMY Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed for First-Line Infertility Treatment and FemVue Diagnostic Globe Newswire 1-Jul-2025 9:00 AM https://marketchameleon.com/PressReleases/i/2121868/FEMY/femasys-achieves-australian-and-new-zealand-regulatory

0 · Reply

HorrMoans Aug. 19 at 8:10 PM

$FEMY Sometimes the suck, sucks. But if no teeth involved then it’s all good.

0 · Reply

HorrMoans Aug. 19 at 8:09 PM

$FEMY I don’t want to be a homer but if you’ve been doing this for awhile then you know what it’s like to have sold too early or wishing you bought more at lower prices when the ship sailed never to be seen again. They, the company said no r/s in their plans so I have no choice but to take their word for it. If they are true to their word then now is the time to Accumulate. IMO.

0 · Reply

MrMcFlurry Aug. 19 at 7:55 PM

$FEMY bought more. Accumulating.

0 · Reply

Drlee5647 Aug. 19 at 7:37 PM

$FEMY huge sell off here

0 · Reply

Drlee5647 Aug. 19 at 7:36 PM

$FEMY another million lost in the cap tommorow below .6

0 · Reply

Femasys Announces Second Quarter Financial Results for 2025

Aug 6, 2025, 9:00 AM EDT - 13 days ago

Femasys Secures First European Order for FemBloc, Marking Strategic Milestone in Global Expansion

Jul 1, 2025, 9:00 AM EDT - 7 weeks ago

Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed® for First-Line Infertility Treatment and FemVue Diagnostic

Jun 25, 2025, 9:00 AM EDT - 7 weeks ago

Femasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth Control

Jun 17, 2025, 9:00 AM EDT - 2 months ago

Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth

Jun 11, 2025, 9:00 AM EDT - 2 months ago

Femasys Announces Partnership with Carolinas Fertility Institute, One of America's Best Fertility Clinics, to Offer FemaSeed® in its More than 8 Locations

May 29, 2025, 4:23 PM EDT - 2 months ago

Femasys Announces Proposed Public Offering of Common Stock and Concurrent Private Placement

May 8, 2025, 5:01 PM EDT - 3 months ago

Femasys Announces Financial Results for Quarter Ended March 31, 2025, and Provides Corporate Update

Mar 27, 2025, 9:00 AM EDT - 5 months ago

Femasys Announces Financial Results for Year Ended December 31, 2024, and Provides Corporate Update

Mar 19, 2025, 9:20 AM EDT - 5 months ago

Femasys Announces Partnership with CNY Fertility, National Conglomerate Network of Fertility Centers, to Offer FemaSeed in its 11 Locations

Mar 18, 2025, 9:00 AM EDT - 5 months ago

Femasys Secures Distribution Partnerships for Commercialization of FemBloc® in Spain

Mar 13, 2025, 8:30 AM EDT - 5 months ago

Femasys Announces FemBloc Delivery System Approval in Europe; A Significant Step Towards FemBloc Permanent Birth Control Availability as the First-Ever Non-Surgical Approach

Feb 25, 2025, 9:20 AM EST - 6 months ago

Femasys Announces Peer-Reviewed Publication of Positive Safety and Efficacy Results from FemBloc® Permanent Birth Control Clinical Trials

Feb 11, 2025, 9:00 AM EST - 6 months ago

Femasys Announces UK Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices

Jan 30, 2025, 8:30 AM EST - 7 months ago

Femasys Announces Notices of Intention to Grant for Two New European Patent Applications Covering Use of FemBloc Permanent Birth Control

Jan 16, 2025, 8:30 AM EST - 7 months ago

Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemaSeed® for Female Infertility Treatment

Nov 26, 2024, 8:30 AM EST - 9 months ago

Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility Treatment

Nov 12, 2024, 8:30 AM EST - 10 months ago

Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update

Nov 1, 2024, 8:30 AM EDT - 10 months ago

Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control

Oct 10, 2024, 8:30 AM EDT - 11 months ago

Femasys to Exhibit at ASRM 2024 and Participate in the Congress' KEEPR Education Program

Oct 2, 2024, 8:30 AM EDT - 11 months ago

Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility Treatments

Sep 18, 2024, 8:30 AM EDT - 11 months ago

Femasys Announces Infertility Clinic Customers from Coast to Coast

Sep 11, 2024, 8:30 AM EDT - 1 year ago

Femasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed® for over $1.3M in Spanish Market

Sep 9, 2024, 8:30 AM EDT - 1 year ago

Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube Check

Sep 5, 2024, 8:30 AM EDT - 1 year ago

Femasys to Exhibit at The Canadian Fertility and Andrology Society's 70th Annual Meeting

Sep 3, 2024, 8:30 AM EDT - 1 year ago

Femasys to Participate in Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 29, 2024, 8:30 AM EDT - 1 year ago

Femasys Announces CE Mark and Canadian Approval for FemVue® MINI, a Fallopian Tube Assessment Solution

Aug 27, 2024, 8:30 AM EDT - 1 year ago

Femasys Hosts Congresswoman Lucy McBath at Georgia Headquarters

Aug 8, 2024, 8:30 AM EDT - 1 year ago

Femasys Announces Financial Results for Quarter Ended June 30, 2024 and Provides Corporate Update

Jun 27, 2024, 8:30 AM EDT - 1 year ago

Femasys to Participate in European Society of Human Reproduction and Embryology 40th Annual Meeting in Amsterdam

May 17, 2024, 8:30 AM EDT - 1 year ago

Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House's Office of Science and Technology Policy to Discuss the Cancer Moonshot Initiative

May 16, 2024, 8:30 AM EDT - 1 year ago

Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House's Gender Policy Council

May 9, 2024, 8:30 AM EDT - 1 year ago

Femasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate Update

May 7, 2024, 8:30 AM EDT - 1 year ago

Femasys Expands Commercial Management Team with Addition of Experienced New Hires

Apr 18, 2024, 8:30 AM EDT - 1 year ago

Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women's Healthcare Initiatives

Mar 28, 2024, 4:05 PM EDT - 1 year ago

Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update

Mar 21, 2024, 9:00 AM EDT - 1 year ago

Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape

Mar 20, 2024, 8:15 AM EDT - 1 year ago

Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility

Mar 6, 2024, 9:00 AM EST - 1 year ago

Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution

Feb 28, 2024, 9:00 AM EST - 1 year ago

Femasys' FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF

Feb 6, 2024, 8:30 AM EST - 1 year ago

Femasys Inc. Advances Commercial Readiness with Appointment of Richard Spector to New Position of Chief Commercial Officer

Jan 26, 2024, 8:00 AM EST - 1 year ago

Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovation and Groundbreaking Research in Health Care for Women

Jan 23, 2024, 8:30 AM EST - 1 year ago

Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recognized Center in Obstetrics and Gynecology

Dec 15, 2023, 8:30 AM EST - 1 year ago

Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at Stanford Medicine

Nov 30, 2023, 8:30 AM EST - 1 year ago

Femasys Inc. Announces the Appointment of James Liu, M.D., as Chief Medical Officer

Nov 28, 2023, 8:40 AM EST - 1 year ago

Femasys: A Women's Health Medical Devices Company Ready To Turn The Corner

Nov 28, 2023, 8:30 AM EST - 1 year ago

Femasys Inc. Completes Enrollment of FemaSeed Pivotal Trial in Support of Commercial Launch

Nov 15, 2023, 8:30 AM EST - 1 year ago

PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women's Health Innovator Femasys, Inc.

PMCB

Nov 15, 2023, 7:30 AM EST - 1 year ago

Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte Biotech

Nov 14, 2023, 7:00 AM EST - 1 year ago

Femasys Inc. Announces Financial Results for the Third Quarter Ended September 30, 2023 and Provides Corporate Update

JJBurch Aug. 20 at 4:05 AM

It appears to me that $PMCB is about to acquire BOTH $TNFA and $FEMY within the next few weeks.

0 · Reply

stoneblood Aug. 20 at 1:19 AM

$FEMY MM's flushing out the impatient before dropping the fembloc FDA approval news grabbed some 0.67s today yum

0 · Reply

Mirto Aug. 20 at 1:11 AM

$FEMY $9000 clearing Thursday. Buying more.

0 · Reply

ExcelsiorHub Aug. 19 at 9:56 PM

$FEMY Bought a small position in @.70 cents.

1 · Reply

NEWBIGTECH Aug. 19 at 9:39 PM

0 · Reply

HorrMoans Aug. 19 at 8:10 PM

$FEMY Sometimes the suck, sucks. But if no teeth involved then it’s all good.

0 · Reply

HorrMoans Aug. 19 at 8:09 PM

0 · Reply

MrMcFlurry Aug. 19 at 7:55 PM

$FEMY bought more. Accumulating.

0 · Reply

Drlee5647 Aug. 19 at 7:37 PM

$FEMY huge sell off here

0 · Reply

Drlee5647 Aug. 19 at 7:36 PM

$FEMY another million lost in the cap tommorow below .6

0 · Reply

TripTrap Aug. 19 at 7:15 PM

$FEMY "Embrace the suck!"

2 · Reply

Mirto Aug. 19 at 5:02 PM

$FEMY [email protected] Ask away.

1 · Reply

4RiskyBusiness4 Aug. 19 at 4:12 PM

$FEMY That’s why she hired commercial and operations officers… great things in store!

0 · Reply

4RiskyBusiness4 Aug. 19 at 3:46 PM

$FEMY If I hadn’t seen this so many other times with other stocks, I’d say the price control was impressive. The fact is that it only takes a few million dollars in reserve to keep the ticker in range — for accumalation.

0 · Reply

Malneily Aug. 19 at 3:40 PM

$FEMY I will keep holding!! It will go up eventually

1 · Reply

marianochoi Aug. 19 at 3:12 PM

$FEMY How far will this stock fall before it starts to rise?

1 · Reply

JohnnyUtah309 Aug. 19 at 3:04 PM

$FEMY still hopeful added a little at $.69

0 · Reply

Trissy08 Aug. 19 at 3:00 PM

$FEMY sadly. That looks to be true.

0 · Reply

Tomlin10 Aug. 19 at 2:59 PM

$FEMY You're probably right and I put this squarely on Kathy. She's failed to impress wall street and never capitalized when the stock had momentum. She's a medical innovator and genius in that regard. However she is not cut out to run a public company. Everyone can keep believing in her... as our stock price hits almost 2 year lows.

0 · Reply

onethestiff Aug. 19 at 2:53 PM

$FEMY we’re going down, down down to reverse split town!

0 · Reply

Drlee5647 Aug. 19 at 1:38 PM

$FEMY Noone is buying this scam

0 · Reply

Drlee5647 Aug. 19 at 1:37 PM

$FEMY just list another million in market cap and newsflash under .7 headed to .3 good luck bulls i would buy more if I was a

0 · Reply

Market Cap	22.81M
Revenue (ttm)	1.63M
Net Income (ttm)	-18.82M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,154.60%
Debt to Equity Ratio	0.07

Volume	417,600
Avg Vol	286,642
Day's Range	N/A - N/A
Shares Out	32.58M
Stochastic %K	10%
Beta	-2.58
Analysts	Strong Sell
Price Target	$6.25